ask="N/A"
ask_size="N/A"
average_daily_volume="20232"
bid="N/A"
bid_size="N/A"
book_value="0.44"
change="+0.15"
change_from_200_day_moving_average="-0.35"
change_from_50_day_moving_average="-1.10"
change_from_52_week_high="-3.10"
change_From_52_week_low="1.90"
change_in_percent="+3.19%"
close="4.85"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.46"
ebitda="-11.23M"
eps_estimate_current_year="-0.42"
eps_estimate_next_quarter="-0.16"
eps_estimate_next_year="-0.50"
ex_dividend_date="N/A"
float_shares="3301000"
high="4.85"
high_52_weeks="7.95"
last_trade_date="2/17/2017"
last_trade_price="4.85"
last_trade_size="100"
last_trade_time="3:59pm"
low="4.70"
low_52_weeks="2.95"
market_capitalization="139.24M"
moving_average_200_day="5.20"
moving_average_50_day="5.95"
name="OncoCyte Corporation"
notes="N/A"
one_year_target_price="9.67"
open="4.75"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-6.72%"
percent_change_from_50_day_moving_average="-18.55%"
percent_change_from_52_week_high="-38.99%"
percent_change_from_52_week_low="+64.41%"
previous_close="4.70"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="10.63"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="28709000"
short_ratio="4.26"
stock_exchange="ASE"
symbol="OCX"
volume="5352"
weeks_range_52="2.95 - 7.95"
